Study of MK0476 (Montelukast Sodium) and Effects on Asthma and Nasal Symptoms Upon Exposure to Cats (0476-256)
Status:
Completed
Trial end date:
2003-01-28
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine the protective effect of an approved medication on
asthma and allergic rhinitis (inflammation of the mucous membrane of the nose) upon exposure
to cats.